DE602006017534D1 - Mitochondriale mutationen und umlagerungen als diagnostisches werkzeug zum nachweis von sonneneinstrahlung, prostatakrebs und anderen krebserkrankungen - Google Patents

Mitochondriale mutationen und umlagerungen als diagnostisches werkzeug zum nachweis von sonneneinstrahlung, prostatakrebs und anderen krebserkrankungen

Info

Publication number
DE602006017534D1
DE602006017534D1 DE602006017534T DE602006017534T DE602006017534D1 DE 602006017534 D1 DE602006017534 D1 DE 602006017534D1 DE 602006017534 T DE602006017534 T DE 602006017534T DE 602006017534 T DE602006017534 T DE 602006017534T DE 602006017534 D1 DE602006017534 D1 DE 602006017534D1
Authority
DE
Germany
Prior art keywords
cancer
rebuildings
diagnostic tool
prostate cancer
mitochondrial mutations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006017534T
Other languages
English (en)
Inventor
Ryan Parr
Robert Thayer
Gabriel Dakubo
Jennifer Maki
Kerry Robinson
Andrea Aguirre
Brian Reguly
Andrew Harbottle
Mark Birch-Machin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitomics Inc
Original Assignee
Mitomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitomics Inc filed Critical Mitomics Inc
Publication of DE602006017534D1 publication Critical patent/DE602006017534D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
DE602006017534T 2005-04-18 2006-04-18 Mitochondriale mutationen und umlagerungen als diagnostisches werkzeug zum nachweis von sonneneinstrahlung, prostatakrebs und anderen krebserkrankungen Active DE602006017534D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US67201605P 2005-04-18 2005-04-18
US72152205P 2005-09-29 2005-09-29
US78987206P 2006-04-07 2006-04-07
PCT/CA2006/000652 WO2006111029A1 (en) 2005-04-18 2006-04-18 Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers

Publications (1)

Publication Number Publication Date
DE602006017534D1 true DE602006017534D1 (de) 2010-11-25

Family

ID=37114687

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006017534T Active DE602006017534D1 (de) 2005-04-18 2006-04-18 Mitochondriale mutationen und umlagerungen als diagnostisches werkzeug zum nachweis von sonneneinstrahlung, prostatakrebs und anderen krebserkrankungen

Country Status (15)

Country Link
US (4) US8008008B2 (de)
EP (2) EP1877559B1 (de)
JP (2) JP5537804B2 (de)
KR (1) KR101363032B1 (de)
CN (2) CN103789405B (de)
AT (1) ATE484589T1 (de)
AU (1) AU2006238390B2 (de)
CA (2) CA2606156C (de)
DE (1) DE602006017534D1 (de)
DK (1) DK1877559T3 (de)
ES (1) ES2354452T3 (de)
NZ (2) NZ562928A (de)
PT (1) PT1877559E (de)
SG (1) SG2014011837A (de)
WO (1) WO2006111029A1 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130022979A1 (en) * 2005-04-18 2013-01-24 Genesis Genomics Inc. 3.4kb MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER
AU2006238390B2 (en) * 2005-04-18 2011-07-28 Mitomics Inc. Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
CN100526453C (zh) * 2005-05-20 2009-08-12 麦克奥迪实业集团有限公司 激光显微切割后细胞收集方法
EP1892302A1 (de) * 2005-06-16 2008-02-27 BIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A. Nukleinsäurenachweisverfahren mit direkter erzeugung eines messbaren signals
US20080254530A1 (en) * 2007-02-27 2008-10-16 Gettysburg College Isolation and characterization of a single mitochondrion
AU2007359381B2 (en) * 2007-09-26 2015-06-18 Mitomics Inc. 3.4 kb mitochondrial DNA deletion for use in the detection of cancer
WO2009046514A1 (en) * 2007-10-11 2009-04-16 Genesis Genomics Inc. Methods for non-invasive collection of skin cells for dna analysis
EP2217730B1 (de) * 2007-10-11 2014-08-20 Mitomics Inc. Verfahren zum testen von mc1r-varianten und mitochondrien-markern in hautproben
AU2008324675B2 (en) * 2007-11-09 2015-04-23 Mdna Life Sciences Inc. Mitochondrial DNA deletion between about residues 12317-16254 for use in the detection of cancer
CN102016039B (zh) * 2008-03-28 2017-06-09 Mdna生命科学有限公司 异常线粒体dna、相关的融合转录物及其杂交探针
EP2743702B1 (de) * 2008-08-28 2017-08-09 Astute Medical, Inc. Verfahren und Zusammensetzungen zur Diagnose und Prognose von Nierenläsion und Niereninsuffizienz
CN105021826A (zh) * 2008-08-29 2015-11-04 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
EP2347260A4 (de) * 2008-10-21 2012-09-26 Astute Medical Inc Verfahren und zusammensetzungen zur diagnose und prognose von nierenverletzungen und niereninsuffizienz
EP3246707B1 (de) 2008-10-21 2020-09-30 Astute Medical, Inc. Verfahren und zusammensetzungen zur diagnose und prognose von nierenläsion und niereninsuffizienz
EP2913676A1 (de) 2008-11-10 2015-09-02 Astute Medical, Inc. Verfahren und zusammensetzungen zur diagnose und prognose von nierenläsion und niereninsuffizienz
NZ592552A (en) * 2008-11-22 2013-12-20 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US9229010B2 (en) 2009-02-06 2016-01-05 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
RU2011137486A (ru) * 2009-03-27 2013-05-10 Митомикс Инк. Аберрантная митохондриальная днк, ассоциированные с ней слитые транскрипты, продукты трансляции и гибрадизационные зонды
CA2760439A1 (en) 2009-04-30 2010-11-04 Good Start Genetics, Inc. Methods and compositions for evaluating genetic markers
EP2462440B1 (de) 2009-08-07 2017-05-17 Astute Medical, Inc. Verfahren und zusammensetzungen zur diagnose und prognose von nierenverletzungen und niereninsuffizienz
MX340078B (es) 2009-11-07 2016-06-24 Astute Medical Inc Metodos y composiciones para el diagnostico y pronostico de daño renal y falla renal.
JP2011115098A (ja) * 2009-12-04 2011-06-16 Nippon Menaade Keshohin Kk 加齢による皮膚明度の低下を予測する皮膚評価方法
NZ600828A (en) 2009-12-20 2014-09-26 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
SI2666872T1 (sl) 2010-02-05 2016-08-31 Astute Medical, Inc. Postopki in sestavki za diagnozo in prognozo ledvične poškodbe in odpovedi ledvic
AU2011269847A1 (en) 2010-02-26 2013-01-31 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2011220413B2 (en) 2010-02-26 2015-07-23 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011106892A1 (en) * 2010-03-01 2011-09-09 Mitomics Inc. Uv associated mtdna fusion transcripts and methods and uses thereof
WO2011162821A1 (en) 2010-06-23 2011-12-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US9163281B2 (en) 2010-12-23 2015-10-20 Good Start Genetics, Inc. Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction
ES2625288T3 (es) 2011-04-15 2017-07-19 The Johns Hopkins University Sistema de secuenciación segura
US9228233B2 (en) 2011-10-17 2016-01-05 Good Start Genetics, Inc. Analysis methods
WO2013086359A1 (en) 2011-12-08 2013-06-13 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US8209130B1 (en) * 2012-04-04 2012-06-26 Good Start Genetics, Inc. Sequence assembly
US8812422B2 (en) 2012-04-09 2014-08-19 Good Start Genetics, Inc. Variant database
US10227635B2 (en) 2012-04-16 2019-03-12 Molecular Loop Biosolutions, Llc Capture reactions
ES2637538T3 (es) * 2012-07-17 2017-10-13 Counsyl, Inc. Sistema y métodos para la detección de una variación genética
ES2701742T3 (es) 2012-10-29 2019-02-25 Univ Johns Hopkins Prueba de Papanicolaou para cánceres de ovario y de endometrio
US9868946B2 (en) * 2012-11-05 2018-01-16 Icahn School Of Medicine At Mount Sinai Method of isolating pure mitochondrial DNA
ES2482866B1 (es) * 2012-11-22 2015-05-12 Consejo Superior De Investigaciones Científicas (Csic) Método de diagnóstico y/o pronóstico de enfermedades neurodegenerativas.
WO2014113558A1 (en) 2013-01-17 2014-07-24 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2971159B1 (de) 2013-03-14 2019-05-08 Molecular Loop Biosolutions, LLC Verfahren zur analyse von nukleinsäuren
WO2014197377A2 (en) 2013-06-03 2014-12-11 Good Start Genetics, Inc. Methods and systems for storing sequence read data
US10851414B2 (en) 2013-10-18 2020-12-01 Good Start Genetics, Inc. Methods for determining carrier status
EP3058096A1 (de) 2013-10-18 2016-08-24 Good Start Genetics, Inc. Verfahren zur beurteilung eines genomischen bereichs einer person
US9745611B2 (en) * 2014-05-06 2017-08-29 Genewiz Inc. Methods and kits for identifying microorganisms in a sample
US11053548B2 (en) 2014-05-12 2021-07-06 Good Start Genetics, Inc. Methods for detecting aneuploidy
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
CN104062294A (zh) * 2014-07-11 2014-09-24 青岛千士医疗科技有限公司 一种支气管/肺上皮细胞线粒体损伤的检测方法
WO2016040446A1 (en) 2014-09-10 2016-03-17 Good Start Genetics, Inc. Methods for selectively suppressing non-target sequences
EP3224595A4 (de) 2014-09-24 2018-06-13 Good Start Genetics, Inc. Prozesssteuerung für erhöhte robustheit von genetischen assays
KR102210104B1 (ko) 2014-10-17 2021-02-01 코디악 사이언시스 인코포레이티드 부티릴콜린에스테라제 양성이온성 중합체 컨쥬게이트
WO2016112073A1 (en) 2015-01-06 2016-07-14 Good Start Genetics, Inc. Screening for structural variants
EP3091083B1 (de) 2015-05-07 2017-11-08 Latvian Biomedical Research and Study Centre Kit zum nachweis von mutation oder von polymorphismus in mitochondrialer dna
EP3115766A1 (de) 2015-07-10 2017-01-11 3Scan Inc. Räumliches multiplexen von histologischen flecken
US11286531B2 (en) 2015-08-11 2022-03-29 The Johns Hopkins University Assaying ovarian cyst fluid
US11243217B2 (en) 2016-06-06 2022-02-08 Astute Medical, Inc. Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
SG11202001010UA (en) 2017-08-07 2020-03-30 Univ Johns Hopkins Methods and materials for assessing and treating cancer
CN108827887B (zh) * 2018-03-19 2021-05-18 陕西学前师范学院 一种商陆基因组大小估计方法及基因组大小测量系统
EP3578671A1 (de) * 2018-06-05 2019-12-11 Universitat Autònoma De Barcelona Verfahren zur beurteilung des risikos auf herz-kreislauf-erkrankung
CN109360656B (zh) * 2018-08-20 2021-11-02 安徽大学 一种基于多目标演化算法的癌症检测方法
US20220220472A1 (en) * 2019-05-06 2022-07-14 The Regents Of The University Of Michigan Targeted therapy
CN110378881B (zh) * 2019-07-05 2020-03-24 北京航空航天大学 一种基于深度学习的肿瘤定位系统
CN110358856B (zh) * 2019-07-23 2023-04-07 四川省农业科学院生物技术核技术研究所 侧耳属线粒体nad4L基因的扩增引物及其在鉴定侧耳属物种中的应用
CN113025633A (zh) * 2019-12-09 2021-06-25 武汉纽福斯生物科技有限公司 编码人nadh脱氢酶亚单位1蛋白的核酸及其应用
WO2021248034A2 (en) * 2020-06-04 2021-12-09 The General Hospital Corporation Methods of detecting mitochondrial diseases
CN117070511B (zh) * 2023-08-16 2024-02-02 广州卿泽生物科技有限公司 一种用于扩增人类线粒体全基因组的引物组及其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2356536A (en) * 1939-07-18 1944-08-22 Rzymkowski Johannes Developing process
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US6027883A (en) 1994-03-30 2000-02-22 Mitokor Optimal procedure for isolation of mutant mitochondrial alleles
US5565323A (en) 1994-03-30 1996-10-15 Mitokor Cytochrome oxidase mutations aiding diagnosis of sporadic alzheimer's disease
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
JPH1099085A (ja) 1996-05-16 1998-04-21 Affymetrix Inc ヒトミトコンドリアｄｎａの多形性
JP3251219B2 (ja) 1997-10-13 2002-01-28 雅嗣 田中 ヒトミトコンドリアｄｎａを用いた遺伝子検出方法
US6605433B1 (en) 1998-08-20 2003-08-12 The Johns Hopkins University Mitochondrial dosimeter
DE69914770T2 (de) 1998-08-20 2005-05-12 The Johns Hopkins University School Of Medicine Mitochondriale, als tumormarker geeignete mutationen, die nur ein basenpaar betreffen
US20020068277A1 (en) * 1998-11-20 2002-06-06 Simpson Andrew John George Method for determining nucleotide sequences using arbitrary primers and low stringency
WO2000063441A2 (en) 1999-04-20 2000-10-26 Mitokor Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease
SE0003286D0 (sv) 2000-09-15 2000-09-15 Ulf Gyllensten Method and kit for human identification
US20030092019A1 (en) 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
US20030162174A1 (en) 2001-06-11 2003-08-28 Sutherland John W. Detecting nucleic acid deletion sequences
US20050026167A1 (en) * 2001-06-11 2005-02-03 Mark Birch-Machin Complete mitochondrial genome sequences as a diagnostic tool for the health sciences
JP2005506057A (ja) 2001-06-11 2005-03-03 １３０４８５４ オンタリオ・リミテッド 健康科学のための診断ツールとしての全ミトコンドリアゲノム配列
US20040191769A1 (en) * 2001-07-24 2004-09-30 Transgenomic, Inc. Methods, compositions, and kits for mutation detection in mitochondrial DNA
CA2356536A1 (en) * 2001-08-30 2003-02-28 Emory University Mitochondrial dna sequence alleles
SE0200817D0 (sv) * 2002-03-15 2002-03-15 Ulf Gyllensten Method and kit for detection of mutations in mitochondrial DNA
US20050244851A1 (en) * 2004-01-13 2005-11-03 Affymetrix, Inc. Methods of analysis of alternative splicing in human
AU2006238390B2 (en) * 2005-04-18 2011-07-28 Mitomics Inc. Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers

Also Published As

Publication number Publication date
CN103789405A (zh) 2014-05-14
EP2339032B1 (de) 2016-12-28
ES2354452T3 (es) 2011-03-15
CA2606156C (en) 2013-01-08
AU2006238390A1 (en) 2006-10-26
NZ587665A (en) 2011-11-25
JP5537804B2 (ja) 2014-07-02
JP2008536496A (ja) 2008-09-11
SG2014011837A (en) 2014-04-28
KR101363032B1 (ko) 2014-02-13
US8008008B2 (en) 2011-08-30
US20120058483A1 (en) 2012-03-08
PT1877559E (pt) 2011-01-19
JP2012179053A (ja) 2012-09-20
EP2339032A1 (de) 2011-06-29
US20090192047A1 (en) 2009-07-30
CN103789405B (zh) 2018-03-30
US10907213B2 (en) 2021-02-02
JP6134890B2 (ja) 2017-05-31
KR20080025040A (ko) 2008-03-19
EP1877559A1 (de) 2008-01-16
EP1877559A4 (de) 2009-06-10
CN101248180B (zh) 2013-09-25
EP1877559B1 (de) 2010-10-13
CA2606156A1 (en) 2006-10-26
ATE484589T1 (de) 2010-10-15
CA2792443A1 (en) 2006-10-26
WO2006111029A1 (en) 2006-10-26
AU2006238390B2 (en) 2011-07-28
US9745632B2 (en) 2017-08-29
US20180105885A1 (en) 2018-04-19
DK1877559T3 (da) 2011-02-07
US20150284805A1 (en) 2015-10-08
NZ562928A (en) 2011-01-28
CN101248180A (zh) 2008-08-20

Similar Documents

Publication Publication Date Title
DE602006017534D1 (de) Mitochondriale mutationen und umlagerungen als diagnostisches werkzeug zum nachweis von sonneneinstrahlung, prostatakrebs und anderen krebserkrankungen
BRPI0607508B8 (pt) método para detecção e/ou classificação de distúrbios proliferativos celulares colorretais ou hepatocelulares, e uso do mesmo
CY1115439T1 (el) Μεθοδοι και νουκλεϊκα οξεα για αναλυσεις διαταραχων του κυτταρικου πολλαπλασιασμου
WO2007008759A3 (en) Methods for detecting and confirming minimal disease in a cancer patient
BR112012014789A2 (pt) aparelho e método para caracterização de tecido, e, meio legível por computador.
AU2002303444A1 (en) Detection of microsatellite instability and its use in diagnosis of tumors
EP4293358A3 (de) Flüchtige organische verbindungen als krebs biomarker
CY1115178T1 (el) Βιοδεικτες καρκινου
WO2007005222A3 (en) Cyanine dyes and methods of use in biological applications
DE602006018578D1 (de) Diagnose- und prognoseverfahren von blasenkrebs.
WO2007089911A3 (en) Methods for detection of circulating tumor cells and methods of diagnosis of cancer in a mammalian subject
ATE520974T1 (de) Raman-spektralanalyse von unter der oberfläche liegenden geweben und flüssigkeiten
WO2007072220A3 (en) Focused microarray and methods of diagnosing cancer
WO2008140463A3 (en) Biomarker panels for assessing radiation injury and exposure
WO2002093130A3 (en) Methods of analyzing chromosomal translocations using fluorescence in situ hybridization (fish)
MX2007008984A (es) Marcadores de cancer y metodos de deteccion.
ATE511636T1 (de) Verfahren zum nachweis biologischer organismen mittels raman-streuung
DK1994410T3 (da) Fremgangsmåder og kits til tidlig påvisning af cancer eller disposition derfor
WO2011087709A3 (en) Eml4-alk translocations in lung cancer
WO2009019370A3 (fr) Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal
WO2007084112A3 (en) Apparatus for performing twin entangled co-incident photon enhanced raman spectroscopy
ATE426162T1 (de) Verfahren zum untersuchen von kírperflussikeiten auf krebszellen sowie entsprechende analysekits
EA200801442A1 (ru) Устройство для сбора бурового раствора
WO2009019369A3 (fr) Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal
WO2005001140A3 (en) Methods and nucleic acids for the analysis of colon cell proliferative disorders